Ustekinumb
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)contractFind a Tender ↗Ref ocds-h6vhtk-047e7a32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
6
Lots
1
6 awarded
Published
04 Apr 2025
Description
Ustekinumab
Scope
- Reference
- PAD-OJEU-56821
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2024 to 30 Sept 2025
This framework includes the option to extend for up to a further 12 months
- Main category
- goods
- Contract locations
- Wales
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail | quality | — |
| Financial (overall cost of contract) | 85 | quality | — |
| Social Value/Community Benefits | 15 | quality | — |
| Price | 85 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 6 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Award 1· 1 supplier
Awarded —
Award value
—
Award 2· 1 supplier
Awarded —
Award value
—
Award 3· 1 supplier
Awarded —
Award value
—
Award 4· 1 supplier
Awarded —
Award value
—
Award 5· 1 supplier
Awarded —
Award value
—
Award 6· 1 supplier
Awarded —
Award value
—
Other contracts from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Celltrion Healthcare Uk Ltd· 7
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Ustekinumab | contract | — | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| Transitional Drugs 6 | contract | — | 30 Mar 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| Transitional Drugs 3 | contract | — | 14 May 2025 |
| Biosimilars and Biologics | contract | — | 26 Jul 2021 |